Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release

Por Trivedi, Madhukar H., Dunner, David L., Kornstein, Susan G., Thase, Michael E., Zajecka, John M., Rothschild, Anthony J., Friedman, Edward S., Shelton, Richard C., Keller, Martin B., Kocsis, James H., Gelenberg, Alan
Publicado em 2010

Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study

Por Rothschild, Anthony J., Dunlop, Boadie W., Dunner, David L., Friedman, Edward S., Gelenberg, Alan, Holland, Peter, Kocsis, James H., Kornstein, Susan G., Shelton, Richard, Trivedi, Madhukar H., Zajecka, John M., Goldstein, Corey, Thase, Michael E., Pedersen, Ron, Keller, Martin B.
Publicado em 2009

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study

Por Sanacora, Gerard, Johnson, Michael R, Khan, Arif, Atkinson, Sarah D, Riesenberg, Robert R, Schronen, Juan P, Burke, Michael A, Zajecka, John M, Barra, Luis, Su, Hong-Lin, Posener, Joel A, Bui, Khanh H, Quirk, Michael C, Piser, Timothy M, Mathew, Sanjay J, Pathak, Sanjeev
Publicado no Neuropsychopharmacology (2017)